The Team
is based in Berlin
We look for investors!
Chemistry & Drug Synthesis:
Thomas Rupp, Scientist
Over 30 years of technical experience in oligonucleotide manufacturing and analytics, Thomas Rupp is a very well-recognized expert and go-to-person in the oligonucleotide field; since mid-2013 Thomas Rupp works as an independent technical and regulatory CMC consultant in the field of therapeutic oligonucleotides.
Scientific Expert
Prof. Georg Sczakiel, PhD
One of major players in the field of academic research and pre-commercial R&D of nucleic acid-based drugs for nearly 30 years; Co-founder of the oligonucleotide therapeutics society (OTS), well established and trustful relationships within academia & industry; Director of the Institute of Molecular Medicine (IMM) of the University of Lübeck, Germany. Transferpreisträger (Preis für beispielgebende Projektaktivitäten im Technologietransfer der Universität zu Lübeck.
